Volume 51, Issue 5, Pages (May 2007)

Slides:

Advertisements

Similar presentations

Volume 70, Issue 2, Pages (August 2016)

Advertisements

Volume 68, Issue 4, Pages (October 2015)

Volume 165, Issue 5, Pages (May 2001)

Volume 67, Issue 1, Pages (January 2015)

Volume 63, Issue 3, Pages (March 2013)

Volume 70, Issue 5, Pages (November 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 58, Issue 2, Pages (August 2010)

Volume 62, Issue 4, Pages (October 2012)

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Volume 60, Issue 2, Pages (August 2011)

Volume 56, Issue 3, Pages (September 2009)

Volume 49, Issue 2, Pages (February 2006)

Volume 61, Issue 5, Pages (May 2012)

Volume 52, Issue 3, Pages (September 2007)

Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 2, Pages (February 2016)

Let the Games Begin (with EAU Approval)

Volume 67, Issue 1, Pages (January 2015)

Volume 52, Issue 4, Pages (October 2007)

Volume 71, Issue 2, Pages (February 2017)

Volume 59, Issue 2, Pages (February 2011)

Volume 63, Issue 1, Pages (January 2013)

Volume 52, Issue 1, Pages (July 2007)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 54, Issue 4, Pages (October 2008)

Volume 65, Issue 3, Pages (March 2014)

Volume 61, Issue 5, Pages (May 2012)

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Cost Effectiveness of Nivolumab in Advanced Renal Cell Carcinoma

Volume 64, Issue 5, Pages (November 2013)

Volume 70, Issue 5, Pages (November 2016)

Early Tumour Shrinkage: A Tool for the Detection of Early Clinical Activity in Metastatic Renal Cell Carcinoma Viktor Grünwald, Xun Lin, Daniel Kalanovic,

Volume 52, Issue 3, Pages (September 2007)

Volume 71, Issue 6, Pages (June 2017)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 53, Issue 2, Pages (February 2008)

Volume 64, Issue 4, Pages (October 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 63, Issue 3, Pages (March 2013)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 59, Issue 1, Pages (January 2011)

Volume 70, Issue 2, Pages (August 2016)

Radical Perineal Prostatectomy and Simultaneous Extended Pelvic Lymph Node Dissection via the Same Incision Hansjörg Keller, Joachim Lehmann, Jörn Beier

Volume 47, Issue 1, Pages (January 2005)

Volume 61, Issue 5, Pages (May 2012)

The Economic Costs of Overactive Bladder in Germany

Volume 53, Issue 1, Pages (January 2008)

Prostate-Specific Antigen Kinetics and Outcomes in Patients with Bone Metastases from Castration-Resistant Prostate Cancer Treated with or Without Zoledronic.

Volume 68, Issue 4, Pages (October 2015)

Volume 50, Issue 5, Pages (November 2006)

Volume 55, Issue 6, Pages (June 2009)

Volume 52, Issue 6, Pages (December 2007)

Volume 71, Issue 5, Pages (May 2017)

The 20-Yr Outcome in Patients with Well- or Moderately Differentiated Clinically Localized Prostate Cancer Diagnosed in the Pre-PSA Era: The Prognostic.

Volume 75, Issue 3, Pages (March 2019)

Volume 71, Issue 3, Pages (March 2017)

European Urology is “Your” Journal

Volume 54, Issue 1, Pages (July 2008)

Volume 52, Issue 4, Pages (October 2007)

Volume 50, Issue 6, Pages (December 2006)

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Volume 52, Issue 1, Pages (July 2007)

European Urology Oncology

Jan Roigas European Urology Supplements

Volume 54, Issue 1, Pages (July 2008)

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 51, Issue 5, Pages 1281-1288 (May 2007) Transitional Cell Carcinoma of the Ureter: Prognostic Factors Influencing Progression and Survival Jan Lehmann, Henrik Suttmann, Iva Kovač, Markus Hack, Jörn Kamradt, Stefan Siemer, Bernd Wullich, Ulrike Zwergel, Michael Stöckle European Urology Volume 51, Issue 5, Pages 1281-1288 (May 2007) DOI: 10.1016/j.eururo.2006.11.021 Copyright © 2006 European Association of Urology Terms and Conditions

Fig. 1 Kaplan-Meier analyses for disease-specific survival in relation to (A) pT stage, (B) grade, (C) serum alkaline phosphatase (AP), and (D) white blood cell (WBC). HR=hazard ratio; CI=confidence interval. European Urology 2007 51, 1281-1288DOI: (10.1016/j.eururo.2006.11.021) Copyright © 2006 European Association of Urology Terms and Conditions